These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6301412)

  • 1. Multiple-drop study of topically applied 1% delta 9-tetrahydrocannabinol in human eyes.
    Jay WM; Green K
    Arch Ophthalmol; 1983 Apr; 101(4):591-3. PubMed ID: 6301412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular effects of topical administration of delta 9-tetrahydrocannabinol in man.
    Green K; Roth M
    Arch Ophthalmol; 1982 Feb; 100(2):265-7. PubMed ID: 6279061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical delta 9-tetrahydrocannabinol and aqueous dynamics in glaucoma.
    Merritt JC; Perry DD; Russell DN; Jones BF
    J Clin Pharmacol; 1981; 21(S1):467S-471S. PubMed ID: 6271841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between delta-9-tetrahydrocannabinol and indomethacin.
    Green K; Kearse EC; McIntyre OL
    Ophthalmic Res; 2001; 33(4):217-20. PubMed ID: 11464074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of delta 9-tetrahydrocannabinol on intraocular pressure after removal of autonomic input.
    Colasanti BK; Powell SR
    J Ocul Pharmacol; 1985; 1(1):47-57. PubMed ID: 2851632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical verapamil and episcleral venous pressure.
    Abreu MM; Kim YY; Shin DH; Netland PA
    Ophthalmology; 1998 Dec; 105(12):2251-5. PubMed ID: 9855155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids in glaucoma II: the effect of different cannabinoids on intraocular pressure of the rabbit.
    ElSohly MA; Harland EC; Benigni DA; Waller CW
    Curr Eye Res; 1984 Jun; 3(6):841-50. PubMed ID: 6329602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical delta 9-tetrahydrocannabinol in hypertensive glaucomas.
    Merritt JC; Olsen JL; Armstrong JR; McKinnon SM
    J Pharm Pharmacol; 1981 Jan; 33(1):40-1. PubMed ID: 6114151
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the ocular and central effects of delta 9-tetrahydrocannabinol and cannabigerol.
    Colasanti BK
    J Ocul Pharmacol; 1990; 6(4):259-69. PubMed ID: 1965836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs.
    Fischer KM; Ward DA; Hendrix DV
    Am J Vet Res; 2013 Feb; 74(2):275-80. PubMed ID: 23363354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of delta 9- and delta 9(11)-tetrahydrocannabinol and their interaction with epinephrine.
    Estrada U; Brase DA; Martin BR; Dewey WL
    Life Sci; 1987 Jul; 41(1):79-87. PubMed ID: 3037218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of delta 9-tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implications.
    Levitt M; Wilson A; Bowman D; Kemel S; Krepart G; Marks V; Schipper H; Thomson G; Weinerman B; Weinerman R
    J Clin Pharmacol; 1981; 21(S1):103S-109S. PubMed ID: 6271814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits.
    Muchtar S; Almog S; Torracca MT; Saettone MF; Benita S
    Ophthalmic Res; 1992; 24(3):142-9. PubMed ID: 1328979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ocular effects of topical instillation of UF-021 ophthalmic solution in healthy volunteers].
    Takase M; Murao M; Koyano S; Okita M; Ueno R
    Nippon Ganka Gakkai Zasshi; 1992 Oct; 96(10):1261-7. PubMed ID: 1442350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical latanoprost and optic nerve head and retinal circulation in humans.
    Tamaki Y; Nagahara M; Araie M; Tomita K; Sandoh S; Tomidokoro A
    J Ocul Pharmacol Ther; 2001 Oct; 17(5):403-11. PubMed ID: 11765145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.
    Hollister LE; Gillespie H
    Clin Pharmacol Ther; 1975 Jul; 18(1):80-3. PubMed ID: 1097148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of brimonidine on aqueous humor dynamics in human eyes.
    Toris CB; Gleason ML; Camras CB; Yablonski ME
    Arch Ophthalmol; 1995 Dec; 113(12):1514-7. PubMed ID: 7487618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of delta-9-tetrahydrocannabinol on intraocular pressure in humans.
    Cooler P; Gregg JM
    South Med J; 1977 Aug; 70(8):951-4. PubMed ID: 329423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of delta 9-tetrahydrocannabinol on intraocular pressure in the anaesthetized cat.
    Innemee HC; Hermans AJ; van Zwieten PA
    Doc Ophthalmol; 1980 Apr; 48(2):235-41. PubMed ID: 6249559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of timolol and UF-021 (a prostaglandin-related compound) on pulsatile ocular blood flow in normal volunteers.
    Kitaya N; Yoshida A; Ishiko S; Mori F; Abiko T; Ogasawara H; Kato Y; Nagaoka T
    Ophthalmic Res; 1997; 29(3):139-44. PubMed ID: 9211466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.